Skip to content

The impact of HIV self-testing on risk compensation in men who have sex with men who oral intake Pre-exposure Prophylaxis

The impact of HIV self-testing on risk compensation in men who have sex with men who oral intake Pre-exposure Prophylaxis: A randomized, waiting list controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800020374
Enrollment
Unknown
Registered
2018-12-27
Start date
2018-12-28
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV/AIDS

Interventions

HIV self-testing group:HIV self-testing kits & HIV standard testing service
control group:HIV standard testing service

Sponsors

The First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Male at birth, and had sex with male sexual partners; 2. Aged 18-65 years old; 3. Subjects who reported one or more of the following risk criteria in the last 6 months: (1) Had unprotected receptive anal sex with a male partner; (2) Had more than 2 male sexual partners; (3) Self-reported sexually transmitted infections (STIs) including syphilis, gonorrhea, chlamydia, chancroid or lymphogranuloma; (4) used post-exposure prophylaxis (PEP) medication, but did not receive PEP in the last 1 month; Note: Subjects who maintain a >1 year single sexual relationship with only one HIV-1 seronegative partner or a virologically suppressed HIV-1+ partner may not participate in the study. 5. At screening, the fourth generation HIV test result should be non-reactive and the HIV-1 RNA should be undetectable; 6. After a comprehensive physical examination (including general physical examination, hematuria, blood biochemical examination, etc.) without serious liver and kidney dysfunction and other indicators in the basic normal range; 7. Those who are informed of the study protocol and who agree to participate in the study and voluntarily sign the informed consent form.

Exclusion criteria

Exclusion criteria: Those who are unwilling to sign informed consent form.

Design outcomes

Primary

MeasureTime frame
HIV self-testing frequency;the occurence of high risk sexual behaviors;recent infection rate of syphilis or HSV-2;

Secondary

MeasureTime frame
STIs treatment adherence;

Countries

China

Contacts

Public ContactJunjie Xu

NHC Key Laboratory of AIDS Immunology (China Medical University), Department of Laboratory Medicine, The First Affiliated Hospital of China Medical University, Shenyang, 110001, China

xjjcmu@163.com+86 15002476278

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026